Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 16, 2021; 9(23): 6725-6733
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6725
Table 1 Clinical material of patients
Clinicopathological feature
Cases
Age (yr)
≤ 5045
> 5043
Sex
Male45
Female43
Tumor diameter
< 5 cm50
≥ 5 cm38
TNM stage
I-II52
III36
Differentiation degree
High differentiation32
Medium/low differentiation56
Lymph node metastasis
Yes40
No48
Hepatitis B surface antigen positivity
Yes72
No16
Portal vein tumor thrombus
Yes50
No38
Table 2 Comparison of caspase-3 and hypoxia inducible factor 1α expression in hepatocellular carcinoma and paracancerous tissues, n (%)
Group
Cases
Positive expression rate of caspase-3
Positive expression rate of HIF-1α
HCC tissues8824 (27.27)64 (72.73)
Paracancerous tissues8872 (81.82)28 (31.82)
χ252.80029.516
P value0.0000.000
Table 3 Relationship between expression of caspase-3 and hypoxia inducible factor 1α and clinical pathology of hepatocellular carcinoma, n (%)
Clinicopathological feature
Cases
Positive expression rate of caspase-3
χ2
P value
Positive expression rate of HIF-1α
χ2
P value
Age (yr)0.4990.4800.0170.896
≤ 50455 (11.11)33 (73.33)
> 50437 (16.28)31 (72.09)
Sex0.2880.5910.1210.728
Male457 (15.56)32 (71.11)
Female435 (11.63)32 (74.42)
Tumor diameter0.0130.9091.3050.253
< 5 cm507 (14.00)34 (68.00)
≥ 5 cm385 (13.16)30 (78.95)
TNM stage4.6390.0315.5020.019
I-II5211 (21.15)33 (63.46)
III361 (2.78)31 (86.11)
Differentiation degree0.5060.4770.0180.892
High differentiation324 (12.50)23 (71.88)
Medium/low differentiation568 (14.29)41 (73.21)
Lymph node metastasis7.7230.00511.6190.001
Yes401 (2.50)22 (55.00)
No4811 (22.92)42 (87.50)
HbsAg positivity0.0001.0000.4970.481
Yes7210 (13.89)54 (75.00)
No162 (12.50)10 (62.50)
Portal vein tumor thrombus0.0130.90913.6170.035
Yes507 (14.00)44 (88.00)
No385 (13.16)22 (52.63)
Table 4 Expression correlation of caspase-3 and hypoxia inducible factor 1α
Caspase-3 expression
HIF-1α
rs
P value
Positive
Negative
Positive39-0.4260.000
Negative6115
Table 5 Multivariate analysis
Index
Hazard ratio (95%CI)
P value
TNM stage1.822 (1.322-3.154)0.000
Portal vein tumor thrombus1.201 (1.092-2.822)0.000
Lymph node metastasis1.143 (1.022-2.560)0.000
Caspase-30.773 (0.573-0.882)0.000
HIF-1α1.211 (1.034-2.432)0.000